These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35663751)

  • 101. Identification of Epithelial Mesenchymal Transition-Related lncRNAs Associated with Prognosis and Tumor Immune Microenvironment of Hepatocellular Carcinoma.
    Zhou Y; Wang L; Zhang W; Ma J; Zhang Z; Yang M; Yu J; Luo J; Yan Z
    Dis Markers; 2022; 2022():6335155. PubMed ID: 35111268
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment.
    Wei X; Wang Y; Ji C; Luan J; Yao L; Zhang X; Wang S; Yao B; Qin C; Song N
    Front Genet; 2021; 12():706661. PubMed ID: 34712264
    [No Abstract]   [Full Text] [Related]  

  • 103. A prognostic 4-lncRNA expression signature for lung squamous cell carcinoma.
    Luo D; Deng B; Weng M; Luo Z; Nie X
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1207-1214. PubMed ID: 28835135
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Bioinformatics analysis based on ferroptosis-related lncRNAs: construction of a clinical prognostic model for nasopharyngeal carcinoma and correlation analysis.
    Dai Z; Zhong Y
    Transl Cancer Res; 2022 Jun; 11(6):1665-1677. PubMed ID: 35836516
    [TBL] [Abstract][Full Text] [Related]  

  • 105. A Novel Risk Model Based on Autophagy-Related LncRNAs Predicts Prognosis and Indicates Immune Infiltration Landscape of Patients With Cutaneous Melanoma.
    Shu Q; Zhou Y; Zhu Z; Chen X; Fang Q; Zhong L; Chen Z; Fang L
    Front Genet; 2022; 13():885391. PubMed ID: 35571053
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Prognostic Value and Immune Landscapes of m5C-Related lncRNAs in Lung Squamous Cell Carcinoma.
    Xu R; Zhang W
    Front Genet; 2022; 13():960229. PubMed ID: 35938020
    [TBL] [Abstract][Full Text] [Related]  

  • 107. A new risk model for CSTA, FAM83A, and MYCT1 predicts poor prognosis and is related to immune infiltration in lung squamous cell carcinoma.
    Ding Y; Bian TT; Li QY; He JR; Guo Q; Wu CY; Chen SS
    Am J Transl Res; 2022; 14(11):7705-7725. PubMed ID: 36505278
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Construction of a Prognostic Model for Hypoxia-Related LncRNAs and Prediction of the Immune Landscape in the Digestive System Pan-Cancer.
    He Z; Liu H; Guan H; Ji J; Jiang Y; Zhang N; Song Z; Wang X; Shen P; Wang H; Cui R
    Front Oncol; 2022; 12():812786. PubMed ID: 35574385
    [TBL] [Abstract][Full Text] [Related]  

  • 109. An Integrative Analysis Identifying RAB40C as an Oncogenic Immune Protein and Prognostic Marker of Lung Squamous Cell Carcinoma.
    Wu H; Dong X; Liao L; Huang L
    Pharmgenomics Pers Med; 2022; 15():525-537. PubMed ID: 35645578
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Identified Gefitinib Metabolism-Related lncRNAs can be Applied to Predict Prognosis, Tumor Microenvironment, and Drug Sensitivity in Non-Small Cell Lung Cancer.
    Ye W; Wu Z; Gao P; Kang J; Xu Y; Wei C; Zhang M; Zhu X
    Front Oncol; 2022; 12():939021. PubMed ID: 35978819
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Identification of Costimulatory Molecule-Related lncRNAs Associated With Gastric Carcinoma Progression: Evidence From Bioinformatics Analysis and Cell Experiments.
    Yin Z; Qiao Y; Shi J; Bu L; Ao L; Tang W; Lu X
    Front Genet; 2022; 13():950222. PubMed ID: 35991571
    [TBL] [Abstract][Full Text] [Related]  

  • 112. N6-Methyladenosine (m
    Zhou Y; Guan X; Wang S; Sun H; Ma H
    J Oncol; 2022; 2022():5240611. PubMed ID: 36090906
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Comprehensive Exploration of M2 Macrophages and Its Related Genes for Predicting Clinical Outcomes and Drug Sensitivity in Lung Squamous Cell Carcinoma.
    Han Y; Li Y
    J Oncol; 2022; 2022():1163924. PubMed ID: 36157235
    [TBL] [Abstract][Full Text] [Related]  

  • 114. A pyroptosis expression pattern score predicts prognosis and immune microenvironment of lung squamous cell carcinoma.
    Chen W; Wen MY; Yang KB; Zheng LT; Li X
    Front Genet; 2022; 13():996444. PubMed ID: 36437960
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Characteristic of Molecular Subtypes in Lung Squamous Cell Carcinoma Based on Autophagy-Related Genes and Tumor Microenvironment Infiltration.
    Wang J; Zhu J; Tang Y; Zhang A; Zhou T; Zhou Y; Shi J
    J Oncol; 2022; 2022():3528142. PubMed ID: 36147441
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Mutational and Transcriptional Characterization Establishes Prognostic Models for Resectable Lung Squamous Cell Carcinoma.
    Liu Y; Duan J; Zhang F; Liu F; Luo X; Shi Y; Lei Y
    Cancer Manag Res; 2023; 15():147-163. PubMed ID: 36824152
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Risk score = LncRNAs associated with doxorubicin metabolism can be used as molecular markers for immune microenvironment and immunotherapy in non-small cell lung cancer.
    Lin Q; Zhang M; Kong Y; Huang Z; Zou Z; Xiong Z; Xie X; Cao Z; Situ W; Dong J; Li S; Zhu X; Huang Y
    Heliyon; 2023 Mar; 9(3):e13811. PubMed ID: 36879965
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Computational recognition of LncRNA signatures in tumor-associated neutrophils could have implications for immunotherapy and prognostic outcome of non-small cell lung cancer.
    Tang Z; Wang Q; Chen P; Guo H; Shi J; Pan Y; Li C; Zhou C
    Front Genet; 2022; 13():1002699. PubMed ID: 36386809
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Single-cell RNA sequencing analysis revealed cellular and molecular immune profiles in lung squamous cell carcinoma.
    Hao B; Zhang Z; Lu Z; Xiong J; Fan T; Song C; He R; Zhang L; Pan S; Li D; Meng H; Lin W; Luo B; Yang J; Li N; Geng Q
    Transl Oncol; 2023 Jan; 27():101568. PubMed ID: 36270103
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Pyroptosis-related lncRNA pairs to estimate the molecular features and prognostic outcomes of pancreatic ductal adenocarcinoma.
    Lu SY; Hua J; Liu J; Wei MY; Liang C; Meng QC; Zhang B; Yu XJ; Wang W; Xu J
    Transl Oncol; 2022 Nov; 25():101524. PubMed ID: 36041293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.